Aldara for the Treatment of Large and/or Multiple sBCC
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
BCC is the most common form of skin cancer. Current treatment is often surgery but this can
be limited by the number of lesions, their location the age of the patient or the potential
cosmetic outcome. The purpose of this study is to evaluate the effectiveness of imiquimod, on
a non surgical treatment, in subjects with multiple of large sBCCs.